Back to XENE
CITADEL ADVISORS LLC XENE Position History
Xenon Pharmaceuticals Inc. • Healthcare
Quarters held
57
Latest value
$513K
Q2 2026
Peak value
$143.4M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $1.4M |
| Q1 2023 | $268K |
| Q1 2023 | $29.3M |
| Q1 2023 | $1.9M |
| Q2 2023 | $527K |
| Q2 2023 | $162K |
| Q2 2023 | $18.9M |
| Q2 2023 | $402K |
| Q3 2023 | $704K |
| Q3 2023 | $714K |
| Q3 2023 | $24.7M |
| Q4 2023 | $778K |
| Q4 2023 | $4.6M |
| Q4 2023 | $2.4M |
| Q4 2023 | $53M |
| Q4 2023 | $5.3M |
| Q1 2024 | $486K |
| Q1 2024 | $452K |
| Q1 2024 | $48.1M |
| Q1 2024 | $7.3M |
| Q2 2024 | $1.2M |
| Q2 2024 | $281K |
| Q2 2024 | $24.5M |
| Q2 2024 | $5.5M |
| Q3 2024 | $661K |
| Q3 2024 | $142K |
| Q3 2024 | $23.9M |
| Q3 2024 | $4.5M |
| Q4 2024 | $576K |
| Q4 2024 | $82K |
| Q4 2024 | $12M |
| Q4 2024 | $814K |
| Q1 2025 | $258K |
| Q1 2025 | $218K |
| Q1 2025 | $23.1M |
| Q2 2025 | $3.8M |
| Q2 2025 | $670K |
| Q2 2025 | $1.1M |
| Q3 2025 | $38.5M |
| Q3 2025 | $895K |
| Q3 2025 | $1.2M |
| Q4 2025 | $58.9M |
| Q4 2025 | $2.8M |
| Q4 2025 | $330K |
| Q4 2025 | $2.1M |
| Q1 2026 | $143.4M |
| Q1 2026 | $6M |
| Q1 2026 | $10.9M |
| Q1 2026 | $7.6M |
| Q2 2026 | $60.7M |
| Q2 2026 | $2.3M |
| Q2 2026 | $23.8M |
| Q2 2026 | $513K |
| Q2 2026 | $60.7M |
| Q2 2026 | $2.3M |
| Q2 2026 | $23.8M |
| Q2 2026 | $513K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $513K | 8.5K | — | — |
| Q2 2026 | $23.8M | 394.8K | — | — |
| Q2 2026 | $2.3M | 38.4K | — | — |
| Q2 2026 | $60.7M | 1.01M | — | — |
| Q2 2026 | $513K | 8.5K | — | — |
| Q2 2026 | $23.8M | 394.8K | — | — |
| Q2 2026 | $2.3M | 38.4K | — | — |
| Q2 2026 | $60.7M | 1.01M | — | — |
| Q1 2026 | $7.6M | 131.0K | — | — |
| Q1 2026 | $10.9M | 187.2K | — | — |
| Q1 2026 | $6M | 102.4K | — | — |
| Q1 2026 | $143.4M | 2.47M | — | — |
| Q4 2025 | $2.1M | 46.9K | — | — |
| Q4 2025 | $330K | 7.4K | — | — |
| Q4 2025 | $2.8M | 61.6K | — | — |
| Q4 2025 | $58.9M | 1.31M | — | — |
| Q3 2025 | $1.2M | 29.3K | — | — |
| Q3 2025 | $895K | 22.3K | — | — |
| Q3 2025 | $38.5M | 959.1K | — | — |
| Q2 2025 | $1.1M | 36.6K | — | — |
| Q2 2025 | $670K | 21.4K | — | — |
| Q2 2025 | $3.8M | 120.0K | — | — |
| Q1 2025 | $23.1M | 687.1K | — | — |
| Q1 2025 | $218K | 6.5K | — | — |
| Q1 2025 | $258K | 7.7K | — | — |
| Q4 2024 | $814K | 20.8K | — | — |
| Q4 2024 | $12M | 306.5K | — | — |
| Q4 2024 | $82K | 2.1K | — | — |
| Q4 2024 | $576K | 14.7K | — | — |
| Q3 2024 | $4.5M | 115.3K | — | — |
| Q3 2024 | $23.9M | 607.2K | — | — |
| Q3 2024 | $142K | 3.6K | — | — |
| Q3 2024 | $661K | 16.8K | — | — |
| Q2 2024 | $5.5M | 141.6K | — | — |
| Q2 2024 | $24.5M | 627.2K | — | — |
| Q2 2024 | $281K | 7.2K | — | — |
| Q2 2024 | $1.2M | 31.8K | — | — |
| Q1 2024 | $7.3M | 168.7K | — | — |
| Q1 2024 | $48.1M | 1.12M | — | — |
| Q1 2024 | $452K | 10.5K | — | — |
| Q1 2024 | $486K | 11.3K | — | — |
| Q4 2023 | $5.3M | 115.1K | — | — |
| Q4 2023 | $53M | 1.15M | — | — |
| Q4 2023 | $2.4M | 52.1K | — | — |
| Q4 2023 | $4.6M | 100.0K | — | — |
| Q4 2023 | $778K | 16.9K | — | — |
| Q3 2023 | $24.7M | 723.5K | — | — |
| Q3 2023 | $714K | 20.9K | — | — |
| Q3 2023 | $704K | 20.6K | — | — |
| Q2 2023 | $402K | 10.4K | — | — |
| Q2 2023 | $18.9M | 490.6K | — | — |
| Q2 2023 | $162K | 4.2K | — | — |
| Q2 2023 | $527K | 13.7K | — | — |
| Q1 2023 | $1.9M | 53.6K | — | — |
| Q1 2023 | $29.3M | 817.6K | — | — |
| Q1 2023 | $268K | 7.5K | — | — |
| Q1 2023 | $1.4M | 38.6K | — | — |
Other funds holding XENE
$136.9M
$118.9M
$118.9M
$100M
$89.1M
$82.9M